3M Firm MMM will launch earnings outcomes for the second quarter, earlier than the opening bell on Friday, July 18.
Analysts anticipate the Saint Paul, Minnesota-based firm to report quarterly earnings at $2.01 per share. It reported $1.93 per share within the earlier yr. 3M can be projected to report quarterly income of $6.05 billion. Examine that to $6.25 billion a yr earlier, in response to information from Benzinga Professional.
On Could 13, the corporate’s board declared a dividend on the corporate’s widespread inventory of 73 cents er share for the second quarter.
3M shares gained 0.9% to shut at $159.04 on Thursday.
Benzinga readers can entry the newest analyst rankings on the Analyst Inventory Scores web page. Readers can kind by inventory ticker, firm title, analyst agency, score change or different variables.
Let’s take a look at how Benzinga’s most-accurate analysts have rated the corporate within the current interval.
Trending Funding Alternatives
- Barclays analyst Julian Mitchell maintained an Obese score and raised the value goal from $164 to $170 on July 9, 2025. This analyst has an accuracy fee of 75%.
- Wells Fargo analyst Joe O’Dea maintained an Obese score and elevated the value goal from $150 to $170 on July 1, 2025. This analyst has an accuracy fee of 64%.
- JP Morgan analyst Stephen Tusa maintained an Obese score and raised the value goal from $140 to $167 on Could 16, 2025. This analyst has an accuracy fee of 68%.
- B of A Securities analyst Andrew Obin maintained a Purchase score and elevated the value goal from $175 to $179 on March 6, 2025. This analyst has an accuracy fee of 73%.
- UBS analyst Damian Karas upgraded the inventory from Impartial to Purchase and raised the value goal from $130 to $184 on Nov. 13, 2024. This analyst has an accuracy fee of 63%
Contemplating shopping for MMM inventory? Right here’s what analysts assume:
Learn This Subsequent:
Picture through Shutterstock
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.